本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Trinity Biotech plc

0.7652
+0.00010.01%
成交量:7,545.00
成交額:5,841.62
市值:1,425.72萬
市盈率:-0.51
高:0.7780
開:0.7752
低:0.7644
收:0.7651
52周最高:3.44
52周最低:0.4800
股本:1,863.20萬
流通股本:1,625.41萬
量比:0.31
換手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):-1.4937
每股收益(LYR):-1.8319
淨資產收益率:-1913.45%
總資產收益率:-9.46%
市淨率:-0.26
市盈率(LYR):-0.42

資料載入中...

2026/01/15

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/05/16

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/26

SEC問詢函

Form CORRESP - Correspondence
2024/11/29

SEC問詢函

Form CORRESP - Correspondence
2024/11/14

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/12

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/06/27

SEC問詢函

Form CORRESP - Correspondence
2024/05/03

SEC問詢函

Form CORRESP - Correspondence
2024/05/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/09

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/03

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/02

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/17

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/08

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/09/12

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/25

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/23

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/02

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]